Summary tables comparing neoplastic disorders: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 64: | Line 64: | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5% | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5% | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |''' | |colspan="1" style = "font-size:90%; color:black;" |'''CD79b''' | ||
|colspan="1" style = "background:#004466;font-size:90%; color:white"|wk | |colspan="1" style = "background:#004466;font-size:90%; color:white"|>80 wk | ||
|colspan="1" style = "background:#004466;"| | |colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80 | ||
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80 | |||
|- | |- | ||
|colspan="1" style = "font-size:90%;" |CD103 | |colspan="1" style = "font-size:90%;" |CD103 | ||
Revision as of 21:52, 21 June 2023
| Immunophenotype LPD | |||
|---|---|---|---|
| Marker | CLL | MCL | FL |
| κ/λ | 40:80 wk | >80 | 40:80 |
| FMC7 | 20:40 wk | 40:80 | 40:80 |
| CD5 | >80 | >80 longer | <5% |
| CD10 | 5-20 | 5-20 | >80 Stg |
| CD11C | 20:40 wk | 20:40 wk | <5% |
| CD19 | >80 | >80 | 40:80 |
| CD20 | >80 | >80 | >80 |
| CD23 | >80 | 5-20 | 40:80 |
| CD25 | 20:40 wk | 20:40 wk | 5-20 wk |
| CD38 | 20:40 | >80 | >80 |
| CD43 | >80 | 40:80 | <5% |
| CD79b | >80 wk | >80 | >80 |
| CD103 | |||
| CD138 | |||
| CD200 | |||
Key to table:
Key to colour code Click for link
Key to expression code Click for link